TherapeuticsMD, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
TherapeuticsMD, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • TherapeuticsMD, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 11.5M shares, a 9.05% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 11.5M +957K +9.05% Jun 30, 2024 10-Q 2024-08-12
Q4 2023 11.5M +2.03M +21.4% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 10.6M +1.11M +11.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 10.6M +1.72M +19.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 9.55M +879K +10.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 9.5M +900K +10.5% Dec 31, 2022 10-K 2024-03-29
Q3 2022 9.47M -415M -97.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 8.86M -386M -97.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 8.67M -385M -97.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 8.6M -291M -97.1% Dec 31, 2021 10-K 2023-04-07
Q3 2021 425M +152M +55.7% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 395M +123M +45.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 393M +122M +44.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 300M +28.6M +10.5% Dec 31, 2020 10-K 2022-03-23
Q3 2020 273M +31.5M +13.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 272M +31.1M +12.9% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 272M +30.5M +12.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 271M +30.7M +12.8% Dec 31, 2019 10-K 2021-03-04
Q3 2019 241M +4.81M +2.04% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 241M +24.4M +11.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 241M +24.6M +11.4% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 240M +24M +11.1% Dec 31, 2018 10-K 2020-02-24
Q3 2018 236M +20M +9.26% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 217M +12.8M +6.28% Jun 30, 2018 10-Q 2018-07-30
Q1 2018 217M +18M +9.06% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 216M +19.7M +10% Dec 31, 2017 10-K 2019-02-27
Q3 2017 216M +19.8M +10.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 204M +7.53M +3.84% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 199M Mar 31, 2017 10-Q 2017-05-03
Q4 2016 197M +18.8M +10.5% Dec 31, 2016 10-K 2018-02-23
Q3 2016 197M +18.8M +10.6% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 196M +23.5M +13.6% Jun 30, 2016 10-Q 2016-08-05
Q4 2015 178M +21.8M +14% Dec 31, 2015 10-K 2017-02-28
Q3 2015 178M +21.8M +13.9% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 173M +27.1M +18.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 173M +27.6M +19% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 156M +11.1M +7.67% Dec 31, 2014 10-K 2016-02-26
Q3 2014 156M +11.1M +7.64% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 146M +14.7M +11.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 145M +15.9M +12.3% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 145M +45.2M +45.3% Dec 31, 2013 10-K 2016-02-26
Q3 2013 145M Sep 30, 2013 10-Q 2013-11-05
Q2 2013 131M Jun 30, 2013 10-Q 2013-08-07
Q1 2013 129M +44.4M +52.3% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 99.8M +16.8M +20.3% Dec 31, 2012 10-K 2014-03-05
Q1 2012 84.8M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 83M +27.5M +49.5% Dec 31, 2011 10-K 2013-03-12
Q3 2011 16.6M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 16.6M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 55.5M Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.